Laboratory of Molecular Cell Biology, National Cancer Tissue Biobank, Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology-Madras, Chennai, India.
Laboratory of Molecular Cell Biology, National Cancer Tissue Biobank, Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology-Madras, Chennai, India.
J Biol Chem. 2021 Aug;297(2):100935. doi: 10.1016/j.jbc.2021.100935. Epub 2021 Jul 3.
Ras-association domain family (RASSF) proteins are encoded by numerous tumor suppressor genes that frequently become silenced in human cancers. RASSF10 is downregulated by promoter hypermethylation in cancers and has been shown to inhibit cell proliferation; however, the molecular mechanism(s) remains poorly understood. Here, we demonstrate for the first time that RASSF10 inhibits Cdk1/cyclin-B kinase complex formation to maintain stable levels of cyclin-B for inducing mitotic arrest during cell cycle. Using LC-MS/MS, live cell imaging, and biochemical approaches, we identify Nucleophosmin (NPM) as a novel functional target of RASSF10 and revealed that RASSF10 expression promoted the nuclear accumulation of GADD45a and knockdown of either NPM or GADD45a, resulting in impairment of RASSF10-mediated G2/M phase arrest. Furthermore, we demonstrate that RASSF10 is a substrate for the E3 ligase ring finger protein 2 (RNF2) and show that an NPM-dependent downregulation of RNF2 expression is critical to maintain stable RASSF10 levels in cells for efficient mitotic arrest. Interestingly, the Kaplan-Meier plot analysis shows a positive correlation of RASSF10 and NPM expression with greater gastric cancer patient survival and the reverse with expression of RNF2, suggesting that they may have a role in cancer progression. Finally, our findings provide insights into the mode of action of the RASSF10/NPM/RNF2 signaling cascade on controlling cell proliferation and may represent a novel therapeutic avenue for the prevention of gastric cancer metastasis.
Ras 相关结构域家族(RASSF)蛋白由许多肿瘤抑制基因编码,这些基因在人类癌症中经常失活。RASSF10 在癌症中因启动子超甲基化而下调,并已被证明能抑制细胞增殖;然而,其分子机制尚不清楚。在这里,我们首次证明 RASSF10 通过抑制 Cdk1/周期蛋白 B 激酶复合物的形成来维持周期蛋白 B 的稳定水平,从而在细胞周期中诱导有丝分裂阻滞。通过 LC-MS/MS、活细胞成像和生化方法,我们确定核磷蛋白(NPM)是 RASSF10 的一种新的功能靶标,并揭示了 RASSF10 表达促进 GADD45a 的核积累,敲低 NPM 或 GADD45a 导致 RASSF10 介导的 G2/M 期阻滞受损。此外,我们证明 RASSF10 是 E3 连接酶环指蛋白 2(RNF2)的底物,并表明 NPM 依赖性下调 RNF2 表达对于维持细胞中稳定的 RASSF10 水平以实现有效的有丝分裂阻滞至关重要。有趣的是,Kaplan-Meier 图分析显示 RASSF10 和 NPM 表达与胃癌患者生存时间延长呈正相关,而 RNF2 表达则相反,这表明它们可能在癌症进展中起作用。最后,我们的研究结果为 RASSF10/NPM/RNF2 信号级联在控制细胞增殖方面的作用机制提供了深入了解,并可能为预防胃癌转移提供新的治疗途径。